The PPARγ ligand, 15-deoxy-Δ12,14-PGJ2, regulates apoptosis-related protein expression in cholangio cell carcinoma cells

被引:0
|
作者
Okano, H
Shiraki, K
Inoue, H
Kawakita, T
Deguchi, M
Sugimoto, K
Sakai, T
Murata, K
Nakano, T
Enjoji, M
机构
[1] Mie Univ, Sch Med, Dept Internal Med 1, Tsu, Mie 5148507, Japan
[2] Kyushu Univ, Grad Sch Med Sci, Dept Med Bioregulat Sci, Fukuoka 812, Japan
关键词
cholangio cell carcinoma cells;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
PPARgamma is known to induce apoptosis in malignant tumor cells, but the mechanism of this induction is not well understood. We investigated induction of apoptosis with 15-Deoxy-Delta(12,14)-prostaglandin J(2) (15d-PGJ(2)), a PPARgamma ligand, in cholangio cell carcinoma (CCC) cells (RBE, ETK-1 or HuCCT-1). Apoptosis was induced in RBE and ETK-1 cells with 15d-PGJ(2), but not in HuCCT-1 cells, although PPARgamma was expressed in all CCC cells. Apoptosis-related proteins were also expressed, including FLIP, bclx, Apaf-1 and XIAP, but expression levels differed among the three cell lines. RBE cells treated with 15d-PGJ(2) showed caspase activation, and it appeared that PPARgamma-induced apoptosis was dependent on caspase activation. However, neither ETK-1 nor HuCCT-1 cells showed significant activation of caspase-8 or -3 with 15d-PGJ(2) treatment, raising the possibility of a caspase-independent apoptosis induction pathway. XIAP was down-regulated by 15d-PGJ(2) in all three CCC cell lines. Therefore, 15d-PGJ(2) induces apoptosis in CCC cells via caspase-dependent or independent pathways. 15d-PGJ(2) may also induce down-regulation of XIAP and may promote caspase cascade activation through TNF-family receptor signaling pathways.
引用
收藏
页码:867 / 870
页数:4
相关论文
共 50 条
  • [21] 15-deoxy-Δ12,14-PGJ2 inhibits IL-6-induced Stat3 phosphorylation in lymphocytes
    Kim, HJ
    Rho, YH
    Choi, SJ
    Lee, YH
    Cheo, HJ
    Um, JW
    Sohn, J
    Song, GG
    Ji, JD
    [J]. EXPERIMENTAL AND MOLECULAR MEDICINE, 2005, 37 (03): : 179 - 185
  • [22] Response to letter by Tsikas et al. 15-deoxy-Δ12,14-PGJ2: An interesting but unapproachable pharmacological target?
    Tsikas, Dimitrios
    Niemann, Jonas
    Beckmann, Bibiana
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 177 (01) : 307 - 309
  • [23] Rosiglitazone alleviates intrahepatic cholestasis induced by α-naphthylisothiocyanate in mice: The role of circulating 15-deoxy-Δ12,14-PGJ2 and Nogo
    Zhang, Shuang
    Yu, Miao
    Guo, Fangling
    Yang, Xiaoxiao
    Chen, Yuanli
    Ma, Chuanrui
    Li, Qi
    Wei, Zhuo
    Li, Xiaoju
    Wang, Hua
    Hu, Huaqing
    Zhang, Yujue
    Kong, Derun
    Miao, Qing Robert
    Hu, Wenquan
    Hajjar, David P.
    Zhu, Yan
    Han, Jihong
    Duan, Yajun
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2020, 177 (05) : 1041 - 1060
  • [24] 15-Deoxy-Δ-12,14-Prostaglandin J2 (15d-PGJ2), an Endogenous Ligand of PPAR-γ: Function and Mechanism
    Li, Jingjing
    Guo, Chuanyong
    Wu, Jianye
    [J]. PPAR RESEARCH, 2019, 2019
  • [25] Oxidized low-density lipoprotein and 15-deoxy-Δ12,14-PGJ2 increase mitochondrial complex I activity in endothelial cells
    Ceaser, EK
    Ramachandran, A
    Levonen, AL
    Darley-Usmar, VM
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2003, 285 (06): : H2298 - H2308
  • [26] Up-regulation of interleukin-8 by 15-deoxy-Δ12,14-PGJ2 in human monocytes and THP-1 cells.
    Zhang, X
    Young, HA
    [J]. FASEB JOURNAL, 2000, 14 (08): : A1355 - A1355
  • [27] High-performance affinity purification for identification of 15-deoxy-Δ12,14-PGJ2 interacting factors using magnetic nanobeads
    Maekawa, Naoya
    Hiramoto, Masaki
    Sakamoto, Satoshi
    Azuma, Motoki
    Ito, Takumi
    Ikeda, Marie
    Naitou, Michitaka
    Acharya, Hukum P.
    Kobayashi, Yuichi
    Suematsu, Makoto
    Handa, Hiroshi
    Imai, Takeshi
    [J]. BIOMEDICAL CHROMATOGRAPHY, 2011, 25 (04) : 466 - 471
  • [28] The cyclopentenone prostaglandin 15-deoxy-Δ 12,14-PGJ2 attenuates the development of colon injury caused by dinitrobenzene sulphonic acid in the rat
    Cuzzocrea, S
    Ianaro, A
    Wayman, NS
    Mazzon, E
    Pisano, B
    Dugo, L
    Serraino, I
    Di Paola, R
    Chatterjee, PK
    Di Rosa, M
    Caputi, AP
    Thiemermann, C
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2003, 138 (04) : 678 - 688
  • [29] Prostaglandin D2 ameliorates acute lung inflammation by activating Nrf2 independent of 15-deoxy-Δ12,14-PGJ2
    Kim, Kyun Ha
    Han, Wei
    Sadikot, Ruxana
    Christman, John
    Breyer, Richard
    Chan, Jefferson
    Urade, Yosihiro
    Oh, Yu-Kyoung
    Blackwell, Timothy
    Joo, Myungsoo
    [J]. JOURNAL OF IMMUNOLOGY, 2013, 190
  • [30] Peroxisome proliferator activator receptor-γ (PPARγ) ligands, 15-deoxy-Δ12,14-PGJ2 (15D-PGJ2) and ciglitazone, provide cardioprotection during reperfusion through different molecular mechanisms.
    Zingarelli, B
    Hake, PW
    O'Connor, M
    Burroughs, TJ
    Denenberg, A
    [J]. SHOCK, 2004, 21 : 62 - 62